Copyright
©2006 Baishideng Publishing Group Co.
World J Gastroenterol. Jul 21, 2006; 12(27): 4325-4330
Published online Jul 21, 2006. doi: 10.3748/wjg.v12.i27.4325
Published online Jul 21, 2006. doi: 10.3748/wjg.v12.i27.4325
Characteristics | n =30 | ||
Etiology (NBNC:B:C) | 10:10:10 | Choline esterase (IU/L) | 262.80 ± 69.34 |
Background (N:CH:LC) | 10:10:10 | Pre-ALB (mg/dL) | 21.92 ± 7.01 |
Sex (M:F) | 22:8 | RBP (mg/dL) | 3.19 ± 1.39 |
Age (yr) | 65.4 ± 10.3 | LCAT (U) | 100.66 ± 25.78 |
BMI | 24.3 ± 3.1 | Apo-A1 (mg/dL) | 136.73 ± 32.43 |
ALB (mg/dL) | 4.03 ± 0.60 | ICGR15 (%) | 12.86 ± 6.44 |
Total Bilirubin (mg/dL) | 0.81 ± 0.28 | Fibrotic area (%) | 15.32 ± 9.69 |
PT (%) | 98.83 ± 16.85 | APRI | 0.69 ± 0.46 |
PT-INR | 1.01 ± 0.16 | FibroScan (kPa) | 15.47 ± 13.02 |
AST (IU/L) | 41.63 ± 21.56 | Hyaluronate (ng/mL) | 120.50 ± 87.71 |
ALT (IU/L) | 37.03 ± 21.58 | Type IV collagen | 6.85 ± 5.11 |
Platelet count (104/μL) | 16.14 ± 4.57 | HGF (ng/dL) | 0.30 ± 0.09 |
ZTT (K-U) | 13.57 ± 9.96 | ||
Fibrotic Area >10% | ||||||
OC | Sens | Speci | SE | 95% CI | AUC | |
FibroScan | 9.1 | 100 | 76.9 | 0.047 | 0.777 - 0.999 | 0.932 |
HA | 96.0 | 76.5 | 84.6 | 0.080 | 0.618 - 0.924 | 0.803 |
Col | 6.6 | 52.9 | 100 | 0.081 | 0.615 - 0.923 | 0.801 |
APRI | 0.57 | 76.5 | 84.6 | 0.081 | 0.615 - 0.923 | 0.801 |
Fibrotic Area > 20% | ||||||
OC | Sens | Speci | SE | 95% CI | AUC | |
FibroScan | 13.6 | 100 | 95.5 | 0.024 | 0.868 - 1.000 | 0.991 |
HA | 106.0 | 100 | 77.3 | 0.061 | 0.797 - 0.993 | 0.946 |
Col | 6.6 | 87.5 | 90.9 | 0.071 | 0.758 - 0.985 | 0.918 |
APRI | 0.58 | 87.5 | 68.2 | 0.098 | 0.642 - 0.937 | 0.824 |
- Citation: Kawamoto M, Mizuguchi T, Katsuramaki T, Nagayama M, Oshima H, Kawasaki H, Nobuoka T, Kimura Y, Hirata K. Assessment of liver fibrosis by a noninvasive method of transient elastography and biochemical markers. World J Gastroenterol 2006; 12(27): 4325-4330
- URL: https://www.wjgnet.com/1007-9327/full/v12/i27/4325.htm
- DOI: https://dx.doi.org/10.3748/wjg.v12.i27.4325